# Wuhan Youngsen Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wuhan-youngsen-biotech

- Industry: Medical Devices & Equipment
- Headquarters: Wuhan, China
- Website: www.youngsen.cn
- Total disclosed funding: $3.3M
- Latest round: Series A (Feb 11, 2015)
- Investors on record: 1

## About

Founded in 2009 and based in Wuhan, China, Wuhan Youngsen Biotech is a medical equipment manufacturer that focuses on research, development, and production of artificial blood vessel products. It has 1,000 square meters of GMP-compliant clean plant. The company has 20 invention patents, and awards honors including the National High-Tech Enterprises. In 2017, It participated in the national key research and development plan project. In June 2020, its YSVG-S02 Artificial Blood Vessel program began clinical trials. In February 2015, Wuhan Youngsen Biotech raised CNY 20 million in series A funding from new investor Shenzhen Capital Group.

Youngsen Biotech's products include the artificial blood vessel VASCULAR GRAFT and the pathway triple-layer bionic small-caliber artificial blood vessel. The products are based on the structure of the human body's arteries.

## Funding rounds

- Series A, Feb 11, 2015, $3.3M — Shenzhen Capital Real Estate Fund

## Investors

- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A